Best evidence topic report. Nebulised magnesium in asthma.
A short cut review was carried out to establish whether the addition of nebulised magnesium sulphate to beta agonist therapy improves outcome in acute asthma. Altogether 69 papers were found using the reported search, of which five presented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these best papers are tabulated. A clinical bottom line is stated.
Costello
Jonathan
J
Department of Emergency Medicine, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK.
Howes
Marten
M
D000208:Acute Disease; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D004630:Emergencies; D019317:Evidence-Based Medicine; D006801:Humans; D008278:Magnesium Sulfate / Q000627:therapeutic use*; D009330:Nebulizers and Vaporizers
D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D008278:Magnesium Sulfate